{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:36:27Z","timestamp":1792892187375,"version":"4.5.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["31\/GATE\/54(06)\/2019-EMR-I"],"award-info":[{"award-number":["31\/GATE\/54(06)\/2019-EMR-I"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["MLP-0204"],"award-info":[{"award-number":["MLP-0204"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12035-025-04776-x","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T15:19:38Z","timestamp":1740755978000},"page":"8603-8623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Decoding the Role of Neurotrophins in Glycogen Synthase Kinase 3-Beta Regulation in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Shubham Nilkanth","family":"Rahmatkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7998-5345","authenticated-orcid":false,"given":"Damanpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"4776_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F et al (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7:e105\u2013e125. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8","journal-title":"Lancet Public Health"},{"key":"4776_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.12688\/f1000research.50786.1","volume":"10","author":"SF Javaid","year":"2021","unstructured":"Javaid SF, Giebel C, Khan MA, Hashim MJ (2021) Epidemiology of Alzheimer\u2019s disease and other dementias: rising global burden and forecasted trends. F1000Res 10:425. https:\/\/doi.org\/10.12688\/f1000research.50786.1","journal-title":"F1000Res"},{"key":"4776_CR3","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1002\/alz.12928","volume":"19","author":"J Lee","year":"2023","unstructured":"Lee J, Meijer E, Langa KM, Ganguli M, Varghese M, Banerjee J et al (2023) Prevalence of dementia in India: national and state estimates from a nationwide study. Alzheimer\u2019s & Dementia 19:2898\u20132912. https:\/\/doi.org\/10.1002\/alz.12928","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"4776_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s12035-023-03578-3","volume":"61","author":"NMA Chimthanawala","year":"2024","unstructured":"Chimthanawala NMA, Haria A, Sathaye S (2024) Non-invasive biomarkers for early detection of Alzheimer\u2019s disease: a new-age perspective. Mol Neurobiol 61:212\u2013223. https:\/\/doi.org\/10.1007\/s12035-023-03578-3","journal-title":"Mol Neurobiol"},{"key":"4776_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy MP, LeVine H (2010) Alzheimer\u2019s disease and the amyloid-\u03b2 peptide. J Alzheimers Dis 19:311\u2013323. https:\/\/doi.org\/10.3233\/JAD-2010-1221","journal-title":"J Alzheimers Dis"},{"key":"4776_CR6","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-160612","volume":"57","author":"R Rajmohan","year":"2017","unstructured":"Rajmohan R, Reddy PH (2017) Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons. J Alzheimers Dis 57:975\u2013999. https:\/\/doi.org\/10.3233\/JAD-160612","journal-title":"J Alzheimers Dis"},{"key":"4776_CR7","doi-asserted-by":"publisher","first-page":"102199","DOI":"10.1016\/j.arr.2024.102199","volume":"94","author":"N Liu","year":"2024","unstructured":"Liu N, Liang X, Chen Y, Xie L (2024) Recent trends in treatment strategies for Alzheimer\u2019s disease and the challenges: a topical advancement. Ageing Res Rev 94:102199. https:\/\/doi.org\/10.1016\/j.arr.2024.102199","journal-title":"Ageing Res Rev"},{"key":"4776_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1601-183X.2007.00378.x","volume":"7","author":"K Schindowski","year":"2008","unstructured":"Schindowski K, Belarbi K, Bu\u00e9e L (2008) Neurotrophic factors in Alzheimer\u2019s disease: role of axonal transport. Genes Brain Behav 7:43\u201356. https:\/\/doi.org\/10.1111\/j.1601-183X.2007.00378.x","journal-title":"Genes Brain Behav"},{"key":"4776_CR9","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s12035-014-8958-4","volume":"52","author":"JH Song","year":"2015","unstructured":"Song JH, Yu JT, Tan L (2015) Brain-derived neurotrophic factor in Alzheimer\u2019s disease: risk, mechanisms, and therapy. Mol Neurobiol 52:1477\u20131493. https:\/\/doi.org\/10.1007\/s12035-014-8958-4","journal-title":"Mol Neurobiol"},{"key":"4776_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12035-012-8310-9","volume":"46","author":"A Cattaneo","year":"2012","unstructured":"Cattaneo A, Calissano P (2012) Nerve growth factor and Alzheimer\u2019s disease: new facts for an old hypothesis. Mol Neurobiol 46:588\u2013604. https:\/\/doi.org\/10.1007\/s12035-012-8310-9","journal-title":"Mol Neurobiol"},{"key":"4776_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/JAD-2008-15210","volume":"15","author":"A Cattaneo","year":"2008","unstructured":"Cattaneo A, Capsoni S, Paoletti F (2008) Towards non invasive nerve growth factor therapies for Alzheimer\u2019s disease. J Alzheimers Dis 15:255\u2013283. https:\/\/doi.org\/10.3233\/JAD-2008-15210","journal-title":"J Alzheimers Dis"},{"key":"4776_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/1567205010666131120100743","volume":"11","author":"K Sopova","year":"2014","unstructured":"Sopova K, Gatsiou K, Stellos K, Laske C (2014) Dysregulation of neurotrophic and haematopoietic growth factors in Alzheimer\u2019s disease: from pathophysiology to novel treatment strategies. Curr Alzheimer Res 11:27\u201339. https:\/\/doi.org\/10.2174\/1567205010666131120100743","journal-title":"Curr Alzheimer Res"},{"key":"4776_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neurobiolaging.2019.07.018","volume":"84","author":"A Shekari","year":"2019","unstructured":"Shekari A, Fahnestock M (2019) Retrograde axonal transport of BDNF and proNGF diminishes with age in basal forebrain cholinergic neurons. Neurobiol Aging 84:131\u2013140. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.07.018","journal-title":"Neurobiol Aging"},{"key":"4776_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.neurobiolaging.2022.10.009","volume":"123","author":"X Li","year":"2023","unstructured":"Li X, Xu M, Bi R, Tan LW, Yao YG, Zhang DF (2023) Common and rare variants of EGF increase the genetic risk of Alzheimer\u2019s disease as revealed by targeted sequencing of growth factors in Han Chinese. Neurobiol Aging 123:170\u2013181. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.10.009","journal-title":"Neurobiol Aging"},{"key":"4776_CR15","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677\u2013736. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.677","journal-title":"Annu Rev Neurosci"},{"key":"4776_CR16","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1242\/jcs.00384","volume":"116","author":"BW Doble","year":"2003","unstructured":"Doble BW, Woodgett JR (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116:1175\u20131186. https:\/\/doi.org\/10.1242\/jcs.00384","journal-title":"J Cell Sci"},{"key":"4776_CR17","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0960-9822(00)00246-3","volume":"4","author":"S Lovestone","year":"1994","unstructured":"Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo JM, Hanger D, Mulot S et al (1994) Alzheimer\u2019s disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 4:1077\u20131086. https:\/\/doi.org\/10.1016\/S0960-9822(00)00246-3","journal-title":"Curr Biol"},{"key":"4776_CR18","doi-asserted-by":"publisher","first-page":"e1001087","DOI":"10.1371\/journal.pgen.1001087","volume":"6","author":"O Sofola","year":"2010","unstructured":"Sofola O, Kerr F, Rogers I, Killick R, Augustin H, Gandy C, Allen MJ, Hardy J et al (2010) Inhibition of GSK-3 ameliorates a\u03b2 pathology in an adult-onset drosophila model of Alzheimer\u2019s disease. PLoS Genet 6:e1001087. https:\/\/doi.org\/10.1371\/journal.pgen.1001087","journal-title":"PLoS Genet"},{"key":"4776_CR19","doi-asserted-by":"publisher","first-page":"864","DOI":"10.2174\/156720512802455386","volume":"9","author":"Z Cai","year":"2012","unstructured":"Cai Z, Zhao Y, Zhao B (2012) Roles of glycogen synthase kinase 3 in Alzheimer\u2019s disease. Curr Alzheimer Res 9:864\u2013879. https:\/\/doi.org\/10.2174\/156720512802455386","journal-title":"Curr Alzheimer Res"},{"key":"4776_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.brainres.2007.10.064","volume":"1188","author":"SH Koh","year":"2008","unstructured":"Koh SH, Noh MY, Kim SH (2008) Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3. Brain Res 1188:254\u2013262. https:\/\/doi.org\/10.1016\/j.brainres.2007.10.064","journal-title":"Brain Res"},{"key":"4776_CR21","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1471-4159.2006.04139.x","volume":"99","author":"T Engel","year":"2006","unstructured":"Engel T, Go\u00f1i-Oliver P, Lucas JJ, Avila J, Hern\u00e1ndez F (2006) Chronic lithium administration to FTDP-17 tau and GSK-3\u03b2 overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. J Neurochem 99:1445\u20131455. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04139.x","journal-title":"J Neurochem"},{"key":"4776_CR22","doi-asserted-by":"publisher","first-page":"8187","DOI":"10.1038\/srep08187","volume":"5","author":"N Jin","year":"2015","unstructured":"Jin N, Yin X, Yu D, Cao M, Gong CX, Iqbal K, Ding F, Gu X et al (2015) Truncation and activation of GSK-3\u03b2 by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer\u2019s disease. Sci Rep 5:8187. https:\/\/doi.org\/10.1038\/srep08187","journal-title":"Sci Rep"},{"key":"4776_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nn.2785","volume":"14","author":"J Jo","year":"2011","unstructured":"Jo J, Whitcomb DJ, Olsen KM, Kerrigan TL, Lo SC, Bru-Mercier G, Dickinson B, Scullion S et al (2011) A\u03b21\u201342 inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3\u03b2. Nat Neurosci 14:545\u2013547. https:\/\/doi.org\/10.1038\/nn.2785","journal-title":"Nat Neurosci"},{"key":"4776_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/alzrt265","volume":"6","author":"Y Kitagishi","year":"2014","unstructured":"Kitagishi Y, Nakanishi A, Ogura Y, Matsuda S (2014) Dietary regulation of PI3K\/AKT\/GSK-3\u03b2 pathway in Alzheimer\u2019s disease. Alzheimers Res Ther 6:35. https:\/\/doi.org\/10.1186\/alzrt265","journal-title":"Alzheimers Res Ther"},{"key":"4776_CR25","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/biom13030570","volume":"13","author":"M Nikolac Perkovic","year":"2023","unstructured":"Nikolac Perkovic M, Borovecki F, Filipcic I, Vuic B, Milos T, Nedic Erjavec G, Konjevod M, Tudor L et al (2023) Relationship between brain-derived neurotrophic factor and cognitive decline in patients with mild cognitive impairment and dementia. Biomolecules 13:570. https:\/\/doi.org\/10.3390\/biom13030570","journal-title":"Biomolecules"},{"key":"4776_CR26","doi-asserted-by":"publisher","first-page":"101791","DOI":"10.1016\/j.arr.2022.101791","volume":"83","author":"PK Jayaswamy","year":"2023","unstructured":"Jayaswamy PK, Vijaykrishnaraj M, Patil P, Alexander LM, Kellarai A, Shetty P (2023) Implicative role of epidermal growth factor receptor and its associated signaling partners in the pathogenesis of Alzheimer\u2019s disease. Ageing Res Rev 83:101791. https:\/\/doi.org\/10.1016\/j.arr.2022.101791","journal-title":"Ageing Res Rev"},{"key":"4776_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11481-013-9509-x","volume":"9","author":"J Chao","year":"2014","unstructured":"Chao J, Yang L, Yao H, Buch S (2014) Platelet-derived growth factor-BB restores HIV Tat -mediated impairment of neurogenesis: role of GSK-3\u03b2\/\u03b2-catenin. J Neuroimmune Pharmacol 9:259\u2013268. https:\/\/doi.org\/10.1007\/s11481-013-9509-x","journal-title":"J Neuroimmune Pharmacol"},{"key":"4776_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/abbs\/gmz156","volume":"52","author":"X Fan","year":"2020","unstructured":"Fan X, Zhao Z, Wang D, Xiao J (2020) Glycogen synthase kinase-3 as a key regulator of cognitive function. Acta Biochim Biophys Sin (Shanghai) 52:219\u2013230. https:\/\/doi.org\/10.1093\/abbs\/gmz156","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"4776_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neuropharm.2018.07.006","volume":"139","author":"AK Rana","year":"2018","unstructured":"Rana AK, Singh D (2018) Targeting glycogen synthase kinase-3 for oxidative stress and neuroinflammation: opportunities, challenges and future directions for cerebral stroke management. Neuropharmacology 139:124\u2013136. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.006","journal-title":"Neuropharmacology"},{"key":"4776_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.arr.2008.11.003","volume":"8","author":"RACM Boonen","year":"2009","unstructured":"Boonen RACM, van Tijn P, Zivkovic D (2009) Wnt signaling in Alzheimer\u2019s disease: up or down, that is the question. Ageing Res Rev 8:71\u201382. https:\/\/doi.org\/10.1016\/j.arr.2008.11.003","journal-title":"Ageing Res Rev"},{"key":"4776_CR31","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"C Hooper","year":"2008","unstructured":"Hooper C, Killick R, Lovestone S (2008) The GSK3 hypothesis of Alzheimer\u2019s disease. J Neurochem 104:1433\u20131439. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05194.x","journal-title":"J Neurochem"},{"key":"4776_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/189246","volume":"2011","author":"P Lei","year":"2011","unstructured":"Lei P, Ayton S, Bush AI, Adlard PA (2011) GSK-3 in neurodegenerative diseases. Int J Alzheimers Dis 2011:1\u20139. https:\/\/doi.org\/10.4061\/2011\/189246","journal-title":"Int J Alzheimers Dis"},{"key":"4776_CR33","doi-asserted-by":"publisher","first-page":"118664","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D (2020) Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Cell Res 1867:118664. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118664","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"4776_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","volume":"148","author":"E Beurel","year":"2015","unstructured":"Beurel E, Grieco SF, Jope RS (2015) Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther 148:114\u2013131. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.016","journal-title":"Pharmacol Ther"},{"key":"4776_CR35","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1055\/s-0044-100186","volume":"68","author":"T Mathuram","year":"2018","unstructured":"Mathuram T, Reece L, Cherian K (2018) GSK-3 inhibitors: a double-edged sword? \u2013 An update on tideglusib. Drug Res 68:436\u2013443. https:\/\/doi.org\/10.1055\/s-0044-100186","journal-title":"Drug Res"},{"key":"4776_CR36","doi-asserted-by":"publisher","unstructured":"Chuang DM, Wang Z, Chiu CT (2011) GSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke. Front Mol Neurosci 4:. https:\/\/doi.org\/10.3389\/fnmol.2011.00015","DOI":"10.3389\/fnmol.2011.00015"},{"key":"4776_CR37","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1126\/science.3306916","volume":"237","author":"R Levi-Montalcini","year":"1979","unstructured":"Levi-Montalcini R (1979) (1987) The nerve growth factor 35 years later. Science 237:1154\u20131162. https:\/\/doi.org\/10.1126\/science.3306916","journal-title":"Science"},{"key":"4776_CR38","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","volume":"72","author":"EJ Huang","year":"2003","unstructured":"Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609\u2013642. https:\/\/doi.org\/10.1146\/annurev.biochem.72.121801.161629","journal-title":"Annu Rev Biochem"},{"key":"4776_CR39","doi-asserted-by":"publisher","first-page":"454","DOI":"10.55782\/ane-2010-1816","volume":"70","author":"K Bartkowska","year":"2010","unstructured":"Bartkowska K, Turlejski K, Djavadian R (2010) Neurotrophins and their receptors in early development of the mammalian nervous system. Acta Neurobiol Exp (Wars) 70:454\u2013467. https:\/\/doi.org\/10.55782\/ane-2010-1816","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"4776_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrn1078","volume":"4","author":"MV Chao","year":"2003","unstructured":"Chao MV (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4:299\u2013309. https:\/\/doi.org\/10.1038\/nrn1078","journal-title":"Nat Rev Neurosci"},{"key":"4776_CR41","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/ijms18030548","volume":"18","author":"K Keefe","year":"2017","unstructured":"Keefe K, Sheikh I, Smith G (2017) Targeting neurotrophins to specific populations of neurons: NGF, BDNF, and NT-3 and their relevance for treatment of spinal cord injury. Int J Mol Sci 18:548. https:\/\/doi.org\/10.3390\/ijms18030548","journal-title":"Int J Mol Sci"},{"key":"4776_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2990.2003.00487.x","volume":"29","author":"D Dawbarn","year":"2003","unstructured":"Dawbarn D, Allen SJ (2003) Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 29:211\u2013230. https:\/\/doi.org\/10.1046\/j.1365-2990.2003.00487.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4776_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/157015911798376190","volume":"9","author":"S J Allen","year":"2011","unstructured":"J Allen S, J Watson J, Dawbarn D (2011) The neurotrophins and their role in Alzheimers disease. Curr Neuropharmacol 9:559\u2013573. https:\/\/doi.org\/10.2174\/157015911798376190","journal-title":"Curr Neuropharmacol"},{"key":"4776_CR44","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s11033-021-06968-9","volume":"49","author":"A Nasrolahi","year":"2022","unstructured":"Nasrolahi A, Javaherforooshzadeh F, Jafarzadeh-Gharehziaaddin M, Mahmoudi J, Asl KD, Shabani Z (2022) Therapeutic potential of neurotrophic factors in Alzheimer\u2019s Disease. Mol Biol Rep 49:2345\u20132357. https:\/\/doi.org\/10.1007\/s11033-021-06968-9","journal-title":"Mol Biol Rep"},{"key":"4776_CR45","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1098\/rstb.2006.1894","volume":"361","author":"LF Reichardt","year":"2006","unstructured":"Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361:1545\u20131564. https:\/\/doi.org\/10.1098\/rstb.2006.1894","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"4776_CR46","doi-asserted-by":"publisher","unstructured":"Skaper SD (2012) The neurotrophin family of neurotrophic factors: an overview. In: Skaper S (eds) Neurotrophic Factors. Methods Mol Biol 846:1\u201312. Humana Press. https:\/\/doi.org\/10.1007\/978-1-61779-536-7_1","DOI":"10.1007\/978-1-61779-536-7_1"},{"key":"4776_CR47","doi-asserted-by":"publisher","first-page":"306","DOI":"10.17712\/nsj.2016.4.20160080","volume":"21","author":"MA Al-Qudah","year":"2016","unstructured":"Al-Qudah MA, Al-Dwairi A (2016) Mechanisms and regulation of neurotrophin synthesis and secretion. Neurosciences 21:306\u2013313. https:\/\/doi.org\/10.17712\/nsj.2016.4.20160080","journal-title":"Neurosciences"},{"key":"4776_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2047-9158-1-14","volume":"1","author":"AM Weissmiller","year":"2012","unstructured":"Weissmiller AM, Wu C (2012) Current advances in using neurotrophic factors to treat neurodegenerative disorders. Transl Neurodegener 1:14. https:\/\/doi.org\/10.1186\/2047-9158-1-14","journal-title":"Transl Neurodegener"},{"key":"4776_CR49","doi-asserted-by":"publisher","unstructured":"Zhou LT, Zhang J, Tan L, Huang HZ, Zhou Y, Liu ZQ, Lu Y, Zhu LQ, et al (2021) Elevated Levels of miR-144\u20133p induce cholinergic degeneration by impairing the maturation of NGF in Alzheimer\u2019s disease. Front Cell Dev Biol 9:. https:\/\/doi.org\/10.3389\/fcell.2021.667412","DOI":"10.3389\/fcell.2021.667412"},{"key":"4776_CR50","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/00207454.2018.1527328","volume":"129","author":"AC Mondal","year":"2019","unstructured":"Mondal AC, Fatima M (2019) Direct and indirect evidences of BDNF and NGF as key modulators in depression: role of antidepressants treatment. Int J Neurosci 129:283\u2013296. https:\/\/doi.org\/10.1080\/00207454.2018.1527328","journal-title":"Int J Neurosci"},{"key":"4776_CR51","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1007\/s12035-023-03328-5","volume":"60","author":"MdM Rahman","year":"2023","unstructured":"Rahman MdM, Islam MdR, Supti FA, Dhar PS, Shohag S, Ferdous J, Shuvo SK, Akter A et al (2023) Exploring the therapeutic effect of neurotrophins and neuropeptides in neurodegenerative diseases: at a glance. Mol Neurobiol 60:4206\u20134231. https:\/\/doi.org\/10.1007\/s12035-023-03328-5","journal-title":"Mol Neurobiol"},{"key":"4776_CR52","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.4103\/1673-5374.358619","volume":"18","author":"M Alfonsetti","year":"2023","unstructured":"Alfonsetti M, d\u2019Angelo M, Castelli V (2023) Neurotrophic factor-based pharmacological approaches in neurological disorders. Neural Regen Res 18:1220. https:\/\/doi.org\/10.4103\/1673-5374.358619","journal-title":"Neural Regen Res"},{"key":"4776_CR53","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1080\/14728222.2020.1846720","volume":"24","author":"AS de Miranda","year":"2020","unstructured":"de Miranda AS, de Barros JLVM, Teixeira AL (2020) Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety? Expert Opin Ther Targets 24:1225\u20131238. https:\/\/doi.org\/10.1080\/14728222.2020.1846720","journal-title":"Expert Opin Ther Targets"},{"key":"4776_CR54","doi-asserted-by":"publisher","first-page":"113162","DOI":"10.1016\/j.bbr.2021.113162","volume":"404","author":"Y Xue","year":"2021","unstructured":"Xue Y, Liang H, Yang R, Deng K, Tang M, Zhang M (2021) The role of pro- and mature neurotrophins in the depression. Behav Brain Res 404:113162. https:\/\/doi.org\/10.1016\/j.bbr.2021.113162","journal-title":"Behav Brain Res"},{"key":"4776_CR55","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pnpbp.2014.09.014","volume":"56","author":"AA Loch","year":"2015","unstructured":"Loch AA, Zanetti MV, de Sousa RT, Chaim TM, Serpa MH, Gattaz WF, Teixeira AL, Machado-Vieira R (2015) Elevated neurotrophin-3 and neurotrophin 4\/5 levels in unmedicated bipolar depression and the effects of lithium. Prog Neuropsychopharmacol Biol Psychiatry 56:243\u2013246. https:\/\/doi.org\/10.1016\/j.pnpbp.2014.09.014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4776_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4209475","volume":"2019","author":"T Jaworski","year":"2019","unstructured":"Jaworski T, Banach-Kasper E, Gralec K (2019) GSK-3 \u03b2 at the intersection of neuronal plasticity and neurodegeneration. Neural Plast 2019:1\u201314. https:\/\/doi.org\/10.1155\/2019\/4209475","journal-title":"Neural Plast"},{"key":"4776_CR57","doi-asserted-by":"publisher","first-page":"102058","DOI":"10.1016\/j.isci.2021.102058","volume":"24","author":"AC Amaral","year":"2021","unstructured":"Amaral AC, Perez-Nievas BG, Siao Tick Chong M, Gonzalez-Martinez A, Argente-Escrig H, Rubio-Guerra S, Commins C, Muftu S et al (2021) Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3\u03b2) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation. iScience 24:102058. https:\/\/doi.org\/10.1016\/j.isci.2021.102058","journal-title":"iScience"},{"key":"4776_CR58","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1471-4159.2011.07349.x","volume":"118","author":"C Hooper","year":"2011","unstructured":"Hooper C, Killick R, Fernandes C, Sugden D, Lovestone S (2011) Transcriptomic profiles of Wnt3a and insulin in primary cultured rat cortical neurones. J Neurochem 118:512\u2013520. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07349.x","journal-title":"J Neurochem"},{"key":"4776_CR59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mcn.2013.04.006","volume":"56","author":"BG Hiester","year":"2013","unstructured":"Hiester BG, Galati DF, Salinas PC, Jones KR (2013) Neurotrophin and Wnt signaling cooperatively regulate dendritic spine formation. Mol Cell Neurosci 56:115\u2013127. https:\/\/doi.org\/10.1016\/j.mcn.2013.04.006","journal-title":"Mol Cell Neurosci"},{"key":"4776_CR60","doi-asserted-by":"publisher","first-page":"102033","DOI":"10.1016\/j.arr.2023.102033","volume":"90","author":"MG Fronza","year":"2023","unstructured":"Fronza MG, Alves D, Pratic\u00f2 D, Savegnago L (2023) The neurobiology and therapeutic potential of multi-targeting \u03b2-secretase, glycogen synthase kinase 3\u03b2 and acetylcholinesterase in Alzheimer\u2019s disease. Ageing Res Rev 90:102033. https:\/\/doi.org\/10.1016\/j.arr.2023.102033","journal-title":"Ageing Res Rev"},{"key":"4776_CR61","doi-asserted-by":"publisher","unstructured":"Anand AA, Khan M, V M, Kar D (2023) The molecular basis of Wnt\/\u03b2-catenin signaling pathways in neurodegenerative diseases. Int J Cell Biol 2023:1\u201313. https:\/\/doi.org\/10.1155\/2023\/9296092","DOI":"10.1155\/2023\/9296092"},{"key":"4776_CR62","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/jmcb\/mjt051","volume":"6","author":"NC Inestrosa","year":"2014","unstructured":"Inestrosa NC, Varela-Nallar L (2014) Wnt signaling in the nervous system and in Alzheimer\u2019s disease. J Mol Cell Biol 6:64\u201374. https:\/\/doi.org\/10.1093\/jmcb\/mjt051","journal-title":"J Mol Cell Biol"},{"key":"4776_CR63","doi-asserted-by":"publisher","unstructured":"Kirouac L, Rajic AJ, Cribbs DH, Padmanabhan J (2017) Activation of Ras-ERK signaling and GSK-3 by amyloid precursor protein and amyloid beta facilitates neurodegeneration in Alzheimer\u2019s disease. eNeuro 4:ENEURO.0149\u201316.2017. https:\/\/doi.org\/10.1523\/ENEURO.0149-16.2017","DOI":"10.1523\/ENEURO.0149-16.2017"},{"key":"4776_CR64","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molcel.2005.06.009","volume":"19","author":"Q Ding","year":"2005","unstructured":"Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y et al (2005) Erk associates with and primes GSK-3\u03b2 for its inactivation resulting in upregulation of \u03b2-catenin. Mol Cell 19:159\u2013170. https:\/\/doi.org\/10.1016\/j.molcel.2005.06.009","journal-title":"Mol Cell"},{"key":"4776_CR65","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10571-022-01191-x","volume":"43","author":"MR Khezri","year":"2023","unstructured":"Khezri MR, Yousefi K, Esmaeili A, Ghasemnejad-Berenji M (2023) The Role of ERK1\/2 Pathway in the pathophysiology of Alzheimer\u2019s disease: an overview and update on new developments. Cell Mol Neurobiol 43:177\u2013191. https:\/\/doi.org\/10.1007\/s10571-022-01191-x","journal-title":"Cell Mol Neurobiol"},{"key":"4776_CR66","doi-asserted-by":"publisher","unstructured":"Bradley CA, Peineau S, Taghibiglou C, Nicolas CS, Whitcomb DJ, Bortolotto ZA, Kaang BK, Cho K, et al (2012) A pivotal role of GSK-3 in synaptic plasticity. Front Mol Neurosci 5:. https:\/\/doi.org\/10.3389\/fnmol.2012.00013","DOI":"10.3389\/fnmol.2012.00013"},{"key":"4776_CR67","doi-asserted-by":"publisher","unstructured":"Fairless R, Bading H, Diem R (2021) Pathophysiological ionotropic glutamate signalling in neuroinflammatory disease as a therapeutic target. Front Neurosci 15:. https:\/\/doi.org\/10.3389\/fnins.2021.741280","DOI":"10.3389\/fnins.2021.741280"},{"key":"4776_CR68","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0143-4160(03)00128-3","volume":"34","author":"MP Mattson","year":"2003","unstructured":"Mattson MP, Chan SL (2003) Neuronal and glial calcium signaling in Alzheimer\u2019s disease. Cell Calcium 34:385\u2013397. https:\/\/doi.org\/10.1016\/S0143-4160(03)00128-3","journal-title":"Cell Calcium"},{"key":"4776_CR69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","volume":"21","author":"R van der Kant","year":"2020","unstructured":"van der Kant R, Goldstein LSB, Ossenkoppele R (2020) Amyloid-\u03b2-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci 21:21\u201335. https:\/\/doi.org\/10.1038\/s41583-019-0240-3","journal-title":"Nat Rev Neurosci"},{"key":"4776_CR70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1755-5949.2010.00221.x","volume":"18","author":"H Hoe","year":"2012","unstructured":"Hoe H, Lee H, Pak DTS (2012) The upside of APP at synapses. CNS Neurosci Ther 18:47\u201356. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00221.x","journal-title":"CNS Neurosci Ther"},{"key":"4776_CR71","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JCB-15035","volume":"2","author":"MB Yerer","year":"2017","unstructured":"Yerer MB, Tiryaki MK, Demirpolat E (2017) GSK-3beta inhibitory effects of 6-gingerol and 6-shogaol help to the recovery of SHSY-5Y cells after amyloid beta1\u201342 oligomer or aggregate toxicity. J Cell Biotechnol 2:145\u2013157. https:\/\/doi.org\/10.3233\/JCB-15035","journal-title":"J Cell Biotechnol"},{"key":"4776_CR72","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/nan.12205","volume":"41","author":"J Amin","year":"2015","unstructured":"Amin J, Paquet C, Baker A, Asuni AA, Love S, Holmes C, Hugon J, Nicoll JAR et al (2015) Effect of amyloid-\u03b2 ( <scp>A<\/scp> \u03b2) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase <scp>(GSK<\/scp> )-3\u03b2. Neuropathol Appl Neurobiol 41:445\u2013457. https:\/\/doi.org\/10.1111\/nan.12205","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4776_CR73","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.nbd.2014.11.020","volume":"74","author":"XH Liu","year":"2015","unstructured":"Liu XH, Geng Z, Yan J, Li T, Chen Q, Zhang QY, Chen ZY (2015) Blocking GSK3\u03b2-mediated dynamin1 phosphorylation enhances BDNF-dependent TrkB endocytosis and the protective effects of BDNF in neuronal and mouse models of Alzheimer\u2019s disease. Neurobiol Dis 74:377\u2013391. https:\/\/doi.org\/10.1016\/j.nbd.2014.11.020","journal-title":"Neurobiol Dis"},{"key":"4776_CR74","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.neurobiolaging.2014.08.005","volume":"36","author":"J Yan","year":"2015","unstructured":"Yan J, Liu XH, Han MZ, Wang YM, Sun XL, Yu N, Li T, Su B et al (2015) Blockage of GSK3\u03b2-mediated Drp1 phosphorylation provides neuroprotection in neuronal and mouse models of Alzheimer\u2019s disease. Neurobiol Aging 36:211\u2013227. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.08.005","journal-title":"Neurobiol Aging"},{"key":"4776_CR75","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12031-021-01824-8","volume":"72","author":"P Girotra","year":"2022","unstructured":"Girotra P, Behl T, Sehgal A, Singh S, Bungau S (2022) Investigation of the molecular role of brain-derived neurotrophic factor in Alzheimer\u2019s disease. J Mol Neurosci 72:173\u2013186. https:\/\/doi.org\/10.1007\/s12031-021-01824-8","journal-title":"J Mol Neurosci"},{"key":"4776_CR76","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/ijms18020268","volume":"18","author":"G Tejeda","year":"2017","unstructured":"Tejeda G, D\u00edaz-Guerra M (2017) Integral characterization of defective BDNF\/TrkB signalling in neurological and psychiatric disorders leads the way to new therapies. Int J Mol Sci 18:268. https:\/\/doi.org\/10.3390\/ijms18020268","journal-title":"Int J Mol Sci"},{"key":"4776_CR77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/JAD-141959","volume":"45","author":"S Lovestone","year":"2015","unstructured":"Lovestone S, Boada M, Dubois B, H\u00fcll M, Rinne JO, Huppertz HJ, Calero M, Andr\u00e9s MV et al (2015) A phase II trial of tideglusib in Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease 45:75\u201388. https:\/\/doi.org\/10.3233\/JAD-141959","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"4776_CR78","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.nbd.2011.09.002","volume":"45","author":"B DaRocha-Souto","year":"2012","unstructured":"DaRocha-Souto B, Coma M, P\u00e9rez-Nievas BG, Scotton TC, Siao M, S\u00e1nchez-Ferrer P, Hashimoto T, Fan Z et al (2012) Activation of glycogen synthase kinase-3 beta mediates \u03b2-amyloid induced neuritic damage in Alzheimer\u2019s disease. Neurobiol Dis 45:425\u2013437. https:\/\/doi.org\/10.1016\/j.nbd.2011.09.002","journal-title":"Neurobiol Dis"},{"key":"4776_CR79","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1460-9568.2006.05245.x","volume":"25","author":"C Hooper","year":"2007","unstructured":"Hooper C, Markevich V, Plattner F, Killick R, Schofield E, Engel T, Hernandez F, Anderton B et al (2007) Glycogen synthase kinase-3 inhibition is integral to long-term potentiation. Eur J Neurosci 25:81\u201386. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.05245.x","journal-title":"Eur J Neurosci"},{"key":"4776_CR80","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon EE, Sigurdsson EM (2018) Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol 14:399\u2013415. https:\/\/doi.org\/10.1038\/s41582-018-0013-z","journal-title":"Nat Rev Neurol"},{"key":"4776_CR81","doi-asserted-by":"publisher","first-page":"856","DOI":"10.22038\/ijbms.2019.30855.7442","volume":"22","author":"S Mehrafza","year":"2019","unstructured":"Mehrafza S, Kermanshahi S, Mostafidi S, Motaghinejad M, Motevalian M, Fatima S (2019) Pharmacological evidence for lithium-induced neuroprotection against methamphetamine-induced neurodegeneration via Akt-1\/GSK3 and CREB-BDNF signaling pathways. Iran J Basic Med Sci 22:856\u2013865. https:\/\/doi.org\/10.22038\/ijbms.2019.30855.7442","journal-title":"Iran J Basic Med Sci"},{"key":"4776_CR82","doi-asserted-by":"publisher","first-page":"110380","DOI":"10.18632\/oncotarget.22777","volume":"8","author":"SY Park","year":"2017","unstructured":"Park SY, Shin HK, Lee WS, Bae SS, Kim K, Hong KW, Kim CD (2017) Neuroprotection by aripiprazole against \u03b2-amyloid-induced toxicity by P-CK2\u03b1 activation via inhibition of GSK-3\u03b2. Oncotarget 8:110380\u2013110391. https:\/\/doi.org\/10.18632\/oncotarget.22777","journal-title":"Oncotarget"},{"key":"4776_CR83","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1073\/pnas.0913572107","volume":"107","author":"S-W Jang","year":"2010","unstructured":"Jang S-W, Liu X, Yepes M, Shepherd KR, Miller GW, Liu Y, Wilson WD, Xiao G, Blanchi B, Sun YE, Ye K (2010) A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci 107:2687\u20132692. https:\/\/doi.org\/10.1073\/pnas.0913572107","journal-title":"Proc Natl Acad Sci"},{"key":"4776_CR84","doi-asserted-by":"publisher","unstructured":"Tan Y, Nie S, Zhu W, Liu F, Guo H, Chu J, Cao XB, Jiang X, et al (2016) 7,8-dihydroxyflavone ameliorates cognitive impairment by inhibiting expression of tau pathology in ApoE-knockout mice. Front Aging Neurosci 8: https:\/\/doi.org\/10.3389\/fnagi.2016.00287","DOI":"10.3389\/fnagi.2016.00287"},{"key":"4776_CR85","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1007\/s00213-020-05602-z","volume":"237","author":"CH Fan","year":"2020","unstructured":"Fan CH, Lin CW, Huang HJ, Lee-Chen GJ, Sun YC, Lin W, Chen CM, Chang KH et al (2020) LMDS-1, a potential TrkB receptor agonist provides a safe and neurotrophic effect for early-phase Alzheimer\u2019s disease. Psychopharmacology 237:3173\u20133190. https:\/\/doi.org\/10.1007\/s00213-020-05602-z","journal-title":"Psychopharmacology"},{"key":"4776_CR86","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2006.07.020","volume":"25","author":"Y Sagi","year":"2007","unstructured":"Sagi Y, Mandel S, Amit T, Youdim MBH (2007) Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism. Neurobiol Dis 25:35\u201344. https:\/\/doi.org\/10.1016\/j.nbd.2006.07.020","journal-title":"Neurobiol Dis"},{"key":"4776_CR87","doi-asserted-by":"publisher","first-page":"e3604","DOI":"10.1371\/journal.pone.0003604","volume":"3","author":"T Yang","year":"2008","unstructured":"Yang T, Knowles JK, Lu Q, Zhang H, Arancio O, Moore LA, Chang T, Wang Q et al (2008) Small molecule, non-peptide p75NTR ligands inhibit A\u03b2-induced neurodegeneration and synaptic impairment. PLoS ONE 3:e3604. https:\/\/doi.org\/10.1371\/journal.pone.0003604","journal-title":"PLoS ONE"},{"key":"4776_CR88","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/WNR.0000000000001352","volume":"30","author":"N Nalinratana","year":"2019","unstructured":"Nalinratana N, Meksuriyen D, Ongpipattanakul B (2019) Asiaticoside but not its aglycone exhibits neuritogenicity through TrkA receptor signaling: a bridge between ERK1\/2-CREB and Akt-GSK3\u03b2\/RhoA. NeuroReport 30:1261\u20131270. https:\/\/doi.org\/10.1097\/WNR.0000000000001352","journal-title":"NeuroReport"},{"key":"4776_CR89","doi-asserted-by":"publisher","first-page":"45937","DOI":"10.1074\/jbc.M306268200","volume":"278","author":"R Bhat","year":"2003","unstructured":"Bhat R, Xue Y, Berg S, Hellberg S, Orm\u00f6 M, Nilsson Y, Rades\u00e4ter AC, Jerning E et al (2003) Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J Biol Chem 278:45937\u201345945. https:\/\/doi.org\/10.1074\/jbc.M306268200","journal-title":"J Biol Chem"},{"key":"4776_CR90","doi-asserted-by":"publisher","first-page":"16329","DOI":"10.1073\/pnas.0706662104","volume":"104","author":"S-W Jang","year":"2007","unstructured":"Jang S-W, Okada M, Sayeed I, Xiao G, Stein D, Jin P, Ye K (2007) Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death. Proc Natl Acad Sci 104:16329\u201316334. https:\/\/doi.org\/10.1073\/pnas.0706662104","journal-title":"Proc Natl Acad Sci"},{"key":"4776_CR91","doi-asserted-by":"publisher","first-page":"e21660","DOI":"10.1371\/journal.pone.0021660","volume":"6","author":"W Chadwick","year":"2011","unstructured":"Chadwick W, Mitchell N, Caroll J, Zhou Y, Park SS, Wang L, Becker KG, Zhang Y et al (2011) Amitriptyline-mediated cognitive enhancement in aged 3\u00d7Tg Alzheimer\u2019s disease mice is associated with neurogenesis and neurotrophic activity. PLoS ONE 6:e21660. https:\/\/doi.org\/10.1371\/journal.pone.0021660","journal-title":"PLoS ONE"},{"key":"4776_CR92","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.bbapap.2012.08.021","volume":"1834","author":"O Obianyo","year":"2013","unstructured":"Obianyo O, Ye K (2013) Novel small molecule activators of the Trk family of receptor tyrosine kinases. Biochim Biophys Acta 1834:2213\u20132218. https:\/\/doi.org\/10.1016\/j.bbapap.2012.08.021","journal-title":"Biochim Biophys Acta"},{"key":"4776_CR93","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuropharm.2015.08.016","volume":"99","author":"S Nie","year":"2015","unstructured":"Nie S, Xu Y, Chen G, Ma K, Han C, Guo Z, Zhang Z, Ye K et al (2015) Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents. Neuropharmacology 99:448\u2013458. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.08.016","journal-title":"Neuropharmacology"},{"key":"4776_CR94","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1021\/acschemneuro.3c00486","volume":"14","author":"RG Roy","year":"2023","unstructured":"Roy RG, Mandal PK, Maroon JC (2023) Oxidative stress occurs prior to amyloid A\u03b2 plaque formation and tau phosphorylation in Alzheimer\u2019s disease: role of glutathione and metal ions. ACS Chem Neurosci 14:2944\u20132954. https:\/\/doi.org\/10.1021\/acschemneuro.3c00486","journal-title":"ACS Chem Neurosci"},{"key":"4776_CR95","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","volume":"4","author":"PP Liu","year":"2019","unstructured":"Liu PP, Xie Y, Meng XY, Kang JS (2019) History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease. Signal Transduct Target Ther 4:29. https:\/\/doi.org\/10.1038\/s41392-019-0063-8","journal-title":"Signal Transduct Target Ther"},{"key":"4776_CR96","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1021\/acs.jmedchem.0c00931","volume":"64","author":"A De Simone","year":"2021","unstructured":"De Simone A, Tumiatti V, Andrisano V, Milelli A (2021) Glycogen synthase kinase 3\u03b2: a new gold rush in anti-Alzheimer\u2019s disease multitarget drug discovery? J Med Chem 64:26\u201341. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00931","journal-title":"J Med Chem"},{"key":"4776_CR97","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1007\/s12011-021-02582-9","volume":"199","author":"H Zhang","year":"2021","unstructured":"Zhang H, Han Y, Zhang L, Jia X, Niu Q (2021) The GSK-3\u03b2\/\u03b2-catenin signaling\u2013mediated brain\u2013derived neurotrophic factor pathway is involved in aluminum-induced impairment of hippocampal LTP in vivo. Biol Trace Elem Res 199:4635\u20134645. https:\/\/doi.org\/10.1007\/s12011-021-02582-9","journal-title":"Biol Trace Elem Res"},{"key":"4776_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuro.2020.06.002","volume":"80","author":"N Kotagale","year":"2020","unstructured":"Kotagale N, Rahmatkar S, Chauragade S, Dixit M, Umekar M, Chopde C, Taksande B (2020) Involvement of hippocampal agmatine in \u03b21-42 amyloid induced memory impairment, neuroinflammation and BDNF signaling disruption in mice. Neurotoxicology 80:1\u201311. https:\/\/doi.org\/10.1016\/j.neuro.2020.06.002","journal-title":"Neurotoxicology"},{"key":"4776_CR99","doi-asserted-by":"publisher","first-page":"135447","DOI":"10.1016\/j.neulet.2020.135447","volume":"740","author":"MP Dixit","year":"2021","unstructured":"Dixit MP, Rahmatkar SN, Raut P, Umekar MJ, Taksande BG, Kotagale NR (2021) Evidences for agmatine alterations in A\u03b21-42induced memory impairment in mice. Neurosci Lett 740:135447. https:\/\/doi.org\/10.1016\/j.neulet.2020.135447","journal-title":"Neurosci Lett"},{"key":"4776_CR100","doi-asserted-by":"publisher","unstructured":"Fahnestock M, Garzon D, Holsinger RMD, Michalski B (2002) Neurotrophic factors and Alzheimer\u2019s disease: are we focusing on the wrong molecule? In: Jellinger KA, Schmidt R, Windisch M (eds) Ageing and dementia current and future concepts. J Neural Transm Suppl 62:241\u201352. Springer, Vienna. https:\/\/doi.org\/10.1007\/978-3-7091-6139-5_22","DOI":"10.1007\/978-3-7091-6139-5_22"},{"key":"4776_CR101","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1016\/j.neurobiolaging.2015.04.014","volume":"36","author":"E Rosa","year":"2015","unstructured":"Rosa E, Fahnestock M (2015) CREB expression mediates amyloid \u03b2-induced basal BDNF downregulation. Neurobiol Aging 36:2406\u20132413. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.04.014","journal-title":"Neurobiol Aging"},{"key":"4776_CR102","doi-asserted-by":"publisher","first-page":"108525","DOI":"10.1016\/j.jnutbio.2020.108525","volume":"87","author":"Petry S dos Santos","year":"2021","unstructured":"dos Santos Petry S, Hoppe JB, Klein CP, dos Santos BG, H\u00f6zer RM, Bifi F, Matt\u00e9 C, Salbego CG et al (2021) Genistein attenuates amyloid-beta-induced cognitive impairment in rats by modulation of hippocampal synaptotoxicity and hyperphosphorylation of Tau. J Nutr Biochem 87:108525. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108525","journal-title":"J Nutr Biochem"},{"key":"4776_CR103","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.expneurol.2009.09.011","volume":"223","author":"F Hern\u00e1ndez","year":"2010","unstructured":"Hern\u00e1ndez F, G\u00f3mez de Barreda E, Fuster-Matanzo A, Lucas JJ, Avila J (2010) GSK3: a possible link between beta amyloid peptide and tau protein. Exp Neurol 223:322\u2013325. https:\/\/doi.org\/10.1016\/j.expneurol.2009.09.011","journal-title":"Exp Neurol"},{"key":"4776_CR104","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.isci.2019.02.029","volume":"13","author":"E Stanganello","year":"2019","unstructured":"Stanganello E, Zahavi EE, Burute M, Smits J, Jordens I, Maurice MM, Kapitein LC, Hoogenraad CC (2019) Wnt signaling directs neuronal polarity and axonal growth. iScience 13:318\u2013327. https:\/\/doi.org\/10.1016\/j.isci.2019.02.029","journal-title":"iScience"},{"key":"4776_CR105","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.neuron.2004.05.011","volume":"42","author":"F-Q Zhou","year":"2004","unstructured":"Zhou F-Q, Zhou J, Dedhar S, Wu YH, Snider WD (2004) NGF-induced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC. Neuron 42:897\u2013912. https:\/\/doi.org\/10.1016\/j.neuron.2004.05.011","journal-title":"Neuron"},{"key":"4776_CR106","doi-asserted-by":"publisher","unstructured":"Rosso SB, Inestrosa NC (2013) WNT signaling in neuronal maturation and synaptogenesis. Front Cell Neurosci 7:. https:\/\/doi.org\/10.3389\/fncel.2013.00103","DOI":"10.3389\/fncel.2013.00103"},{"key":"4776_CR107","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, Khachaturian AS, Vergallo A et al (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain 141:1917\u20131933. https:\/\/doi.org\/10.1093\/brain\/awy132","journal-title":"Brain"},{"key":"4776_CR108","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25:5789. https:\/\/doi.org\/10.3390\/molecules25245789","journal-title":"Molecules"},{"key":"4776_CR109","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00204-015-1540-7","volume":"90","author":"J del Pino","year":"2016","unstructured":"del Pino J, Zeballos G, Anad\u00f3n MJ, Moyano P, D\u00edaz MJ, Garc\u00eda JM, Frejo MT (2016) Cadmium-induced cell death of basal forebrain cholinergic neurons mediated by muscarinic M1 receptor blockade, increase in GSK-3\u03b2 enzyme, \u03b2-amyloid and tau protein levels. Arch Toxicol 90:1081\u20131092. https:\/\/doi.org\/10.1007\/s00204-015-1540-7","journal-title":"Arch Toxicol"},{"key":"4776_CR110","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.tox.2018.04.003","volume":"402\u2013403","author":"P Moyano","year":"2018","unstructured":"Moyano P, Frejo MT, Anadon MJ, Garc\u00eda JM, D\u00edaz MJ, Lobo M, Sola E, Garc\u00eda J et al (2018) SN56 neuronal cell death after 24 h and 14 days chlorpyrifos exposure through glutamate transmission dysfunction, increase of GSK-3\u03b2 enzyme, \u03b2-amyloid and tau protein levels. Toxicology 402\u2013403:17\u201327. https:\/\/doi.org\/10.1016\/j.tox.2018.04.003","journal-title":"Toxicology"},{"key":"4776_CR111","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1007\/s12035-020-02009-x","volume":"57","author":"M Hern\u00e1ndez-Rodr\u00edguez","year":"2020","unstructured":"Hern\u00e1ndez-Rodr\u00edguez M, Arciniega-Mart\u00ednez IM, Garc\u00eda-Mar\u00edn ID, Correa-Basurto J, Rosales-Hern\u00e1ndez MC (2020) Chronic administration of scopolamine increased GSK3\u03b2P9, beta secretase, amyloid beta, and oxidative stress in the hippocampus of Wistar rats. Mol Neurobiol 57:3979\u20133988. https:\/\/doi.org\/10.1007\/s12035-020-02009-x","journal-title":"Mol Neurobiol"},{"key":"4776_CR112","doi-asserted-by":"publisher","first-page":"328","DOI":"10.21037\/atm.2020.02.138","volume":"8","author":"C Yang","year":"2020","unstructured":"Yang C, Bao X, Zhang L, Li Y, Li L, Zhang L (2020) Cornel iridoid glycoside ameliorates cognitive deficits in APP\/PS1\/tau triple transgenic mice by attenuating amyloid-beta, tau hyperphosphorylation and neurotrophic dysfunction. Ann Transl Med 8:328. https:\/\/doi.org\/10.21037\/atm.2020.02.138","journal-title":"Ann Transl Med"},{"key":"4776_CR113","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1471-4159.2008.05837.x","volume":"108","author":"M Noh","year":"2009","unstructured":"Noh M, Koh S, Kim Y, Kim HY, Cho GW, Kim SH (2009) Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-\u03b2-induced neuronal cell death. J Neurochem 108:1116\u20131125. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05837.x","journal-title":"J Neurochem"},{"key":"4776_CR114","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3233\/jad-2002-4404","volume":"4","author":"RV Bhat","year":"2002","unstructured":"Bhat RV, Leonov S, Luthman J, Scott CW, Lee CM (2002) Interactions between GSK3beta and caspase signalling pathways during NGF deprivation induced cell death. J Alzheimers Dis 4:291\u2013301. https:\/\/doi.org\/10.3233\/jad-2002-4404","journal-title":"J Alzheimers Dis"},{"key":"4776_CR115","doi-asserted-by":"publisher","first-page":"e104937","DOI":"10.1371\/journal.pone.0104937","volume":"9","author":"H-L Tsai","year":"2014","unstructured":"Tsai H-L, Deng WP, Lai WFT, Chiu WT, Yang CB, Tsai YH, Hwang SM, Renshaw PF (2014) Wnts enhance neurotrophin-induced neuronal differentiation in adult bone-marrow-derived mesenchymal stem cells via canonical and noncanonical signaling pathways. PLoS ONE 9:e104937. https:\/\/doi.org\/10.1371\/journal.pone.0104937","journal-title":"PLoS ONE"},{"key":"4776_CR116","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tips.2008.09.001","volume":"29","author":"D Pratic\u00f2","year":"2008","unstructured":"Pratic\u00f2 D (2008) Oxidative stress hypothesis in Alzheimer\u2019s disease: a reappraisal. Trends Pharmacol Sci 29:609\u2013615. https:\/\/doi.org\/10.1016\/j.tips.2008.09.001","journal-title":"Trends Pharmacol Sci"},{"key":"4776_CR117","doi-asserted-by":"publisher","first-page":"117187","DOI":"10.1016\/j.jep.2023.117187","volume":"319","author":"SN Rahmatkar","year":"2024","unstructured":"Rahmatkar SN, Rana AK, Kumar R, Singh D (2024) Fagopyrum tataricum (L.) Gaertn interacts with Gsk-3\u03b2\/Nrf-2 signalling to protect neurotoxicity in a zebrafish model. J Ethnopharmacol 319:117187. https:\/\/doi.org\/10.1016\/j.jep.2023.117187","journal-title":"J Ethnopharmacol"},{"key":"4776_CR118","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cytogfr.2020.08.002","volume":"58","author":"AK Rana","year":"2021","unstructured":"Rana AK, Rahmatkar SN, Kumar A, Singh D (2021) Glycogen synthase kinase-3: a putative target to combat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Cytokine Growth Factor Rev 58:92\u2013101. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.08.002","journal-title":"Cytokine Growth Factor Rev"},{"key":"4776_CR119","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"E T\u00f6nnies","year":"2017","unstructured":"T\u00f6nnies E, Trushina E (2017) Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease 57:1105\u20131121. https:\/\/doi.org\/10.3233\/JAD-161088","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"4776_CR120","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.redox.2017.10.010","volume":"14","author":"A Cuadrado","year":"2018","unstructured":"Cuadrado A, K\u00fcgler S, Lastres-Becker I (2018) Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy. Redox Biol 14:522\u2013534. https:\/\/doi.org\/10.1016\/j.redox.2017.10.010","journal-title":"Redox Biol"},{"key":"4776_CR121","doi-asserted-by":"publisher","first-page":"173412","DOI":"10.1016\/j.ejphar.2020.173412","volume":"886","author":"MdS Uddin","year":"2020","unstructured":"Uddin MdS, Al Mamun A, Kabir MdT, Ahmad J, Jeandet P, Sarwar MdS, Ashraf GM, Aleya L (2020) Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration. Eur J Pharmacol 886:173412. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173412","journal-title":"Eur J Pharmacol"},{"key":"4776_CR122","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.arcmed.2012.10.016","volume":"43","author":"RA Quintanilla","year":"2012","unstructured":"Quintanilla RA, Orellana JA, von Bernhardi R (2012) Understanding risk factors for Alzheimer\u2019s disease: interplay of neuroinflammation, connexin-based communication and oxidative stress. Arch Med Res 43:632\u2013644. https:\/\/doi.org\/10.1016\/j.arcmed.2012.10.016","journal-title":"Arch Med Res"},{"key":"4776_CR123","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s12035-016-9795-4","volume":"54","author":"A Ahmad","year":"2017","unstructured":"Ahmad A, Ali T, Park HY, Badshah H, Rehman SU, Kim MO (2017) Neuroprotective effect of fisetin against amyloid-beta-induced cognitive\/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult mice. Mol Neurobiol 54:2269\u20132285. https:\/\/doi.org\/10.1007\/s12035-016-9795-4","journal-title":"Mol Neurobiol"},{"key":"4776_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.07.003","volume":"61","author":"EE Spangenberg","year":"2017","unstructured":"Spangenberg EE, Green KN (2017) Inflammation in Alzheimer\u2019s disease: lessons learned from microglia-depletion models. Brain Behav Immun 61:1\u201311. https:\/\/doi.org\/10.1016\/j.bbi.2016.07.003","journal-title":"Brain Behav Immun"},{"key":"4776_CR125","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3233\/JAD-131076","volume":"40","author":"M Feld","year":"2014","unstructured":"Feld M, Krawczyk MC, Sol Fusti\u00f1ana M, Blake MG, Baratti CM, Romano A, Boccia MM (2014) Decrease of ERK\/MAPK overactivation in prefrontal cortex reverses early memory deficit in a mouse model of Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease 40:69\u201382. https:\/\/doi.org\/10.3233\/JAD-131076","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"4776_CR126","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jns.2014.06.037","volume":"345","author":"Q Lv","year":"2014","unstructured":"Lv Q, Lan W, Sun W, Ye R, Fan X, Ma M, Yin Q, Jiang Y et al (2014) Intranasal nerve growth factor attenuates tau phosphorylation in brain after traumatic brain injury in rats. J Neurol Sci 345:48\u201355. https:\/\/doi.org\/10.1016\/j.jns.2014.06.037","journal-title":"J Neurol Sci"},{"key":"4776_CR127","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-022-00279-0","volume":"11","author":"L Gao","year":"2022","unstructured":"Gao L, Zhang Y, Sterling K, Song W (2022) Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential. Transl Neurodegener 11:4. https:\/\/doi.org\/10.1186\/s40035-022-00279-0","journal-title":"Transl Neurodegener"},{"key":"4776_CR128","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.tips.2021.06.006","volume":"42","author":"SC Malik","year":"2021","unstructured":"Malik SC, Sozmen EG, Baeza-Raja B, Le Moan N, Akassoglou K, Schachtrup C (2021) In vivo functions of p75NTR: challenges and opportunities for an emerging therapeutic target. Trends Pharmacol Sci 42:772\u2013788. https:\/\/doi.org\/10.1016\/j.tips.2021.06.006","journal-title":"Trends Pharmacol Sci"},{"key":"4776_CR129","doi-asserted-by":"publisher","first-page":"104567","DOI":"10.1016\/j.nbd.2019.104567","volume":"132","author":"LL Shen","year":"2019","unstructured":"Shen LL, Li WW, Xu YL, Gao SH, Xu MY, Bu XL, Liu YH, Wang J et al (2019) Neurotrophin receptor p75 mediates amyloid \u03b2-induced tau pathology. Neurobiol Dis 132:104567. https:\/\/doi.org\/10.1016\/j.nbd.2019.104567","journal-title":"Neurobiol Dis"},{"key":"4776_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8820406","volume":"2021","author":"MS Uddin","year":"2021","unstructured":"Uddin MS, Mamun AA, Rahman MM, Jeandet P, Alexiou A, Behl T, Sarwar MS, Sobarzo-S\u00e1nchez E et al (2021) Natural products for neurodegeneration: regulating neurotrophic signals. Oxid Med Cell Longev 2021:1\u201317. https:\/\/doi.org\/10.1155\/2021\/8820406","journal-title":"Oxid Med Cell Longev"},{"key":"4776_CR131","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1002\/jcp.27255","volume":"234","author":"Z Tan","year":"2019","unstructured":"Tan Z, Kang T, Zhang X, Tong Y, Chen S (2019) Nerve growth factor prevents arsenic-induced toxicity in PC12 cells through the AKT\/GSK-3\u03b2\/NFAT pathway. J Cell Physiol 234:4726\u20134738. https:\/\/doi.org\/10.1002\/jcp.27255","journal-title":"J Cell Physiol"},{"key":"4776_CR132","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1021\/cn5000309","volume":"5","author":"OV Forlenza","year":"2014","unstructured":"Forlenza OV, De-Paula VJR, Diniz BSO (2014) Neuroprotective effects of lithium: implications for the treatment of Alzheimer\u2019s disease and related neurodegenerative disorders. ACS Chem Neurosci 5:443\u2013450. https:\/\/doi.org\/10.1021\/cn5000309","journal-title":"ACS Chem Neurosci"},{"key":"4776_CR133","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1192\/bjp.bp.110.080044","volume":"198","author":"OV Forlenza","year":"2011","unstructured":"Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF (2011) Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry 198:351\u2013356. https:\/\/doi.org\/10.1192\/bjp.bp.110.080044","journal-title":"Br J Psychiatry"},{"key":"4776_CR134","doi-asserted-by":"publisher","first-page":"136044","DOI":"10.1016\/j.neulet.2021.136044","volume":"760","author":"R Haussmann","year":"2021","unstructured":"Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M (2021) Minireview: Lithium: a therapeutic option in Alzheimer\u2019s disease and its prodromal stages? Neurosci Lett 760:136044. https:\/\/doi.org\/10.1016\/j.neulet.2021.136044","journal-title":"Neurosci Lett"},{"key":"4776_CR135","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrn2870","volume":"11","author":"E-M Hur","year":"2010","unstructured":"Hur E-M, Zhou F-Q (2010) GSK3 signalling in neural development. Nat Rev Neurosci 11:539\u2013551. https:\/\/doi.org\/10.1038\/nrn2870","journal-title":"Nat Rev Neurosci"},{"key":"4776_CR136","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/14728222.2018.1526925","volume":"22","author":"P Duda","year":"2018","unstructured":"Duda P, Wi\u015bniewski J, W\u00f3jtowicz T, W\u00f3jcicka O, Ja\u015bkiewicz M, Drulis-Fajdasz D, Rakus D, McCubrey JA et al (2018) Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging. Expert Opin Ther Targets 22:833\u2013848. https:\/\/doi.org\/10.1080\/14728222.2018.1526925","journal-title":"Expert Opin Ther Targets"},{"key":"4776_CR137","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/CIRCRESAHA.116.303613","volume":"116","author":"H Lal","year":"2015","unstructured":"Lal H, Ahmad F, Woodgett J, Force T (2015) The GSK-3 family as therapeutic target for myocardial diseases. Circ Res 116:138\u2013149. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303613","journal-title":"Circ Res"},{"key":"4776_CR138","doi-asserted-by":"publisher","first-page":"e0189485","DOI":"10.1371\/journal.pone.0189485","volume":"12","author":"T de Groot","year":"2017","unstructured":"de Groot T, Damen L, Kosse L, Alsady M, Doty R, Baumgarten R, Sheehan S, van der Vlag J et al (2017) Lithium reduces blood glucose levels, but aggravates albuminuria in BTBR-ob\/ob mice. PLoS ONE 12:e0189485. https:\/\/doi.org\/10.1371\/journal.pone.0189485","journal-title":"PLoS ONE"},{"key":"4776_CR139","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1476-5381.1994.tb14817.x","volume":"111","author":"OG Hermida","year":"1994","unstructured":"Hermida OG, Fontela T, Ghiglione M, Uttenthal LO (1994) Effect of lithium on plasma glucose, insulin and glucagon in normal and streptozotocin-diabetic rats: role of glucagon in the hyperglycaemic response. Br J Pharmacol 111:861\u2013865. https:\/\/doi.org\/10.1111\/j.1476-5381.1994.tb14817.x","journal-title":"Br J Pharmacol"},{"key":"4776_CR140","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2121-8-34","volume":"8","author":"A Tighe","year":"2007","unstructured":"Tighe A, Ray-Sinha A, Staples OD, Taylor SS (2007) GSK-3 inhibitors induce chromosome instability. BMC Cell Biol 8:34. https:\/\/doi.org\/10.1186\/1471-2121-8-34","journal-title":"BMC Cell Biol"},{"key":"4776_CR141","doi-asserted-by":"publisher","first-page":"13249","DOI":"10.1038\/srep13249","volume":"5","author":"Y Yoshino","year":"2015","unstructured":"Yoshino Y, Ishioka C (2015) Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells. Sci Rep 5:13249. https:\/\/doi.org\/10.1038\/srep13249","journal-title":"Sci Rep"},{"key":"4776_CR142","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35017574","volume":"406","author":"KP Hoeflich","year":"2000","unstructured":"Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR (2000) Requirement for glycogen synthase kinase-3\u03b2 in cell survival and NF-\u03baB activation. Nature 406:86\u201390. https:\/\/doi.org\/10.1038\/35017574","journal-title":"Nature"},{"key":"4776_CR143","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1038\/sj.emboj.7601725","volume":"26","author":"R G\u00f3mez-Sintes","year":"2007","unstructured":"G\u00f3mez-Sintes R, Hern\u00e1ndez F, Bortolozzi A, Artigas F, Avila J, Zaratin P, Gotteland JP, Lucas JJ (2007) Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice. EMBO J 26:2743\u20132754. https:\/\/doi.org\/10.1038\/sj.emboj.7601725","journal-title":"EMBO J"},{"key":"4776_CR144","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1007\/s12035-023-03839-1","volume":"61","author":"RC Sequeira","year":"2024","unstructured":"Sequeira RC, Godad A (2024) Understanding glycogen synthase kinase-3: a novel avenue for Alzheimer\u2019s disease. Mol Neurobiol 61:4203\u20134221. https:\/\/doi.org\/10.1007\/s12035-023-03839-1","journal-title":"Mol Neurobiol"},{"key":"4776_CR145","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.nbd.2008.11.004","volume":"33","author":"C Cunha","year":"2009","unstructured":"Cunha C, Angelucci A, D\u2019Antoni A, Dobrossy MD, Dunnett SB, Berardi N, Brambilla R (2009) Brain-derived neurotrophic factor (BDNF) overexpression in the forebrain results in learning and memory impairments. Neurobiol Dis 33:358\u2013368. https:\/\/doi.org\/10.1016\/j.nbd.2008.11.004","journal-title":"Neurobiol Dis"},{"key":"4776_CR146","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/44847","volume":"401","author":"KW Kafitz","year":"1999","unstructured":"Kafitz KW, Rose CR, Thoenen H, Konnerth A (1999) Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 401:918\u2013921. https:\/\/doi.org\/10.1038\/44847","journal-title":"Nature"},{"key":"4776_CR147","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/0896-6273(94)90219-4","volume":"12","author":"CS von Bartheld","year":"1994","unstructured":"von Bartheld CS, Kinoshita Y, Prevette D, Yin Q-W, Oppenheim RW, Bothwell M (1994) Positive and negative effects of neurotrophins on the isthmo-optic nucleus in chick embryos. Neuron 12:639\u2013654. https:\/\/doi.org\/10.1016\/0896-6273(94)90219-4","journal-title":"Neuron"},{"key":"4776_CR148","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0014-4886(95)90045-4","volume":"131","author":"MA Pelleymounter","year":"1995","unstructured":"Pelleymounter MA, Cullen MJ, Wellman CL (1995) Characteristics of BDNF-induced weight loss. Exp Neurol 131:229\u2013238. https:\/\/doi.org\/10.1016\/0014-4886(95)90045-4","journal-title":"Exp Neurol"},{"key":"4776_CR149","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.joca.2013.06.004","volume":"21","author":"MF Seidel","year":"2013","unstructured":"Seidel MF, Wise BL, Lane NE (2013) Nerve growth factor: an update on the science and therapy. Osteoarthritis Cartilage 21:1223\u20131228. https:\/\/doi.org\/10.1016\/j.joca.2013.06.004","journal-title":"Osteoarthritis Cartilage"},{"key":"4776_CR150","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.21873\/anticanres.11783","volume":"37","author":"DP Radin","year":"2017","unstructured":"Radin DP, Patel P (2017) BDNF: an oncogene or tumor suppressor? Anticancer Res 37:3983\u20133990. https:\/\/doi.org\/10.21873\/anticanres.11783","journal-title":"Anticancer Res"},{"key":"4776_CR151","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00432-022-04365-8","volume":"149","author":"M Malekan","year":"2023","unstructured":"Malekan M, Nezamabadi SS, Samami E, Mohebalizadeh M, Saghazadeh A, Rezaei N (2023) BDNF and its signaling in cancer. J Cancer Res Clin Oncol 149:2621\u20132636. https:\/\/doi.org\/10.1007\/s00432-022-04365-8","journal-title":"J Cancer Res Clin Oncol"},{"key":"4776_CR152","doi-asserted-by":"publisher","first-page":"F45","DOI":"10.1152\/ajprenal.00386.2017","volume":"315","author":"MP Kashyap","year":"2018","unstructured":"Kashyap MP, Pore SK, de Groat WC, Chermansky CJ, Yoshimura N, Tyagi P (2018) BDNF overexpression in the bladder induces neuronal changes to mediate bladder overactivity. Am J Physiol Renal Physiol 315:F45\u2013F56. https:\/\/doi.org\/10.1152\/ajprenal.00386.2017","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04776-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04776-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04776-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:52:18Z","timestamp":1751381538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04776-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":152,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4776"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04776-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}